Provided by Tiger Trade Technology Pte. Ltd.

Tango Therapeutics Inc.

20.88
+1.407.19%
Pre-market: 21.030.1478+0.71%08:17 EDT
Volume:4.37M
Turnover:91.83M
Market Cap:2.98B
PE:-23.87
High:21.82
Open:19.60
Low:19.60
Close:19.48
52wk High:21.82
52wk Low:1.03
Shares:142.69M
Float Shares:59.76M
Volume Ratio:1.10
T/O Rate:7.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8746
EPS(LYR):-0.8746
ROE:-37.23%
ROA:-19.45%
PB:8.61
PE(LYR):-23.87

Loading ...

Tango Therapeutics President, R&D Crystal Adam Disposes of Common Shares

Reuters
·
Feb 28

Analysts Are Bullish on Top Healthcare Stocks: Intellia Therapeutics (NTLA), Tango Therapeutics (TNGX)

TIPRANKS
·
Feb 27

Tango Therapeutics weakness an ‘over reaction,’ says Stifel

TIPRANKS
·
Feb 27

Earning Preview: Tango Therapeutics Inc. this quarter’s revenue is expected to decrease by 93.56%, and institutional views are bullish

Earnings Agent
·
Feb 26

Tango Therapeutics Inc : Mizuho Initiates Coverage With Outperform Rating; Target Price $19

THOMSON REUTERS
·
Feb 23

Tango Therapeutics Inc. Publishes Update to Financial Calendar

Reuters
·
Feb 18

Guggenheim Keeps Their Buy Rating on Tango Therapeutics (TNGX)

TIPRANKS
·
Feb 06

Tango Therapeutics CFO Daniella Beckman Reports Disposal of Common Shares

Reuters
·
Feb 05

Tango Therapeutics CEO to Join Guggenheim Emerging Outlook Biotech Summit

Reuters
·
Feb 03

A Look At Tango Therapeutics (TNGX) Valuation After CEO Transition And Strong Recent Share Price Returns

Simply Wall St.
·
Jan 22

Tango Therapeutics, Inc.'s (NASDAQ:TNGX) 53% Price Boost Is Out Of Tune With Revenues

Simply Wall St.
·
Jan 19

Is Tango Therapeutics’ New CEO (TNGX) Quietly Redefining Its Clinical Strategy And Execution Priorities?

Simply Wall St.
·
Jan 18

Tango Therapeutics (TNGX) Valuation Check After Leadership Reshuffle And Strong Recent Share Price Performance

Simply Wall St.
·
Jan 15

Tango Therapeutics Unveils Pipeline Advancements Targeting MTAP-Deleted Cancers

Reuters
·
Jan 14

Tango Therapeutics announces retirement of CEO Weber, Peters to succeed

TIPRANKS
·
Jan 08

Tango Therapeutics Names Malte Peters CEO as Barbara Weber Retires

Reuters
·
Jan 08

Tango Therapeutics Inc - Malte Peters Appointed President and CEO of Tango Therapeutics

THOMSON REUTERS
·
Jan 08

Tango Therapeutics Inc - Barbara Weber to Become Executive Chair in 2026

THOMSON REUTERS
·
Jan 08

Tango Therapeutics Inc. Files Initial Statement of Beneficial Ownership for Director Sung Lee

Reuters
·
Jan 07

Press Release: Tango Therapeutics Appoints Sung Lee to Board of Directors

Dow Jones
·
Jan 05